DSB 2002 Program

Session 1: Fast-Tracking Research with DNA arrays
Tom Freeman, MRC Human Genome Mapping Programme, Cambridge: Prospects for microarray analysis in an academic setting
Charles Mackay, Garvan Medical Research Institute, Sydney: Affymetrix gene profiling for inflammatory diseases, and integration with Celera database, SNP detection, and disease association
Andrew Holloway, PeterMac, Melbourne: Gene arrays and cancer classification
Martin McCall, Centre for Immunology: Complete human genome screen for novel anti-inflammatory targets

Session 2: Stem Cells, development, and biotechnology
Peter Rathjen, University of Adelaide: Stem cells and the future of medicine
Hirofumi Doi, Celestar  Lexico-Sciences: A slant on stem cells, learned from gene expression of mouse early embryos

Session 3: Commercialising Biodiscovery
David Adamthwaite, Baldwin Shelston Waters: Protect or publish?
Lee Ridge, Photonics CRC: Linking Research to Finance
Mark Bradley, ATP-Innovations: The long and winding road: biotechnology commercialisation in Australia

Session 4: Evolution of a Biotech Company
Peter Colman, Biota: Early history of Biota
Peter Gage, Biotron: Commercialisation of university research: from academia to the ASX

Session 5: Biotechnology platforms of the 21st Century
Richard Harrison, Applera: Faster, stronger, higher; the technologies driving the genomic revolution.
Bruce Cornell, AMBRI: Biosensors
Andrew Gooley, Proteome Systems: ProteomIQ - an automated and integrated proteomic platform

Session 6: Proteomics
Dolores Cahill, MPI, Berlin: Protein arrays: Generation and applications
Richard Simpson, Ludwig Institute, Melbourne: Protein analysis beyond 2D gels
John Whitelock, CSIRO: Proteomic analysis of proteoglycans

Session 7: Arrays in novel applications
Robyn Ward, St Vincent's Hospital, Sydney: New cancer therapies, the cup runneth over
Richard Christopherson, University of Sydney: Immunophenotyping of leukemias using a cluster of differentiation antibody microarray
Els N Meeusen, University of Melbourne: Novel sheep asthma model for drug discovery and formulation

Session 8: Global Biotechnology Opportunities
Ken-ichi Arai, Japan: Pacific Rim Biotechnology
Eugen Takagi, Xcelerator, Japan: Japanese bio venture today and strong needs of overseas collaboration
Gabor Lamm, EMBLEM, Germany: Innovation to Commercialisation: A European Perspective

Conference Committee

May 16-17, 2003, Dockside, Cockle Bay Wharf, Sydney, Australia

Convenor
Professor Keith Stanley,
Centre for Immunology, St Vincents Hospital, Darlinghurst NSW Australia

Co-convenor
Dr Peter French,
Centre for Immunology, St Vincents Hospital, Darlinghurst NSW Australia